NIH-funded study points to long-acting HIV treatment; USC team finds prostate cancer target;

> An NIH-funded project has found a long-acting HIV treatment that may one day do away with the need for daily antiretrovirals. Release

> Scientists at USC say they have pinpointed a new therapeutic target for prostate cancer. Release

> Researchers at the University of Maryland School of Medicine say they have discovered a protein that plays a key role in regulating heart beats. Release

> Advanced DNA sequencing tech has revealed a gene that plays a key role in sporadic ALS, or Lou Gehrig's disease. Release

Suggested Articles

Researchers discovered that inactivating a subtype of the protein beta-arrestin-2 in mice restored the ability of the brain to dispose of toxic tau.

A newfound link between BMAL1, a protein involved in circadian rhythms, and triple-negative breast cancer could point to new treatment strategies.

Combining a DYRK1A inhibitor with popular GLP-1 receptor agonists regenerates insulin-producing beta cells, Mount Sinai scientists found.